Pancreatic Cancer Research

ResearcherNorthwestern UniversityActive in the last 2 years

Halla Sayed Nimeiri

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8760-6456; OpenAlex author ID A5052504293. Sources: ClinicalTrials.gov.

Their work

Papers
3
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2011: 1 paper, 1 trial · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. Real-World Validation of the Purity Independent Subtyping of Tumors Classifier for Informing Therapy Selection in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1200/po-25-00197↗
  2. Ipilimumab and Gemcitabine for Advanced Pancreatic Cancer: A Phase Ib Study. Co-author DOI 10.1634/theoncologist.2019-0473↗
  3. Therapy of locally advanced pancreatic adenocarcinoma: unresectable and borderline patients. Co-author DOI 10.1586/era.11.125↗

Trials 1

  1. Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery Principal investigator NCT01465659↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Al B. Benson · 3 shared papers, 2011–2025 · strength 0.35
  2. Stéphane Wenric · 1 shared paper, 2025 · strength 0.20
  3. Charles M. Perou · 1 shared paper, 2025 · strength 0.20
  4. Sheetal Mehta Kircher · 2 shared papers, 2011–2020 · strength 0.16
  5. Mary F. Mulcahy · 2 shared papers, 2011–2020 · strength 0.16
  6. Suneel Deepak Kamath · 1 shared paper, 2020 · strength 0.13
  7. Aparna Kalyan · 1 shared paper, 2020 · strength 0.13
  8. Seth B. Krantz · 1 shared paper, 2011 · strength 0.03
  9. Hidayatullah G. Munshi · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.